Sreepathi Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Telangana, Telangana, India, established in 1983.
1983 Telangana, Telangana, India Active
Last Updated:
Access Report
About Sreepathi Pharmaceuticals Limited

Sreepathi Pharmaceuticals Limited, a active public limited company, was established on 29 December 1983 in Telangana, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239TG1983PLC004356. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.20 Cr and a paid-up capital of ₹3.70 Cr.

It upholds a compliant status. Employing 119 professional, Its leadership includes Srinivas Isola (Managing Director), Satya Isola Akhil (Director), Karthik Isola Chandra (Director). Past directors included Pawan Kumar Agrawall, Ramachandra Mantha Rao, Peri Srinivasa Sharma. It holds ₹70.24 Cr open charges and ₹46.68 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot.No.22B, H.No.8-2-293/82/A/22/B, Road.No.2, Jubilee Hills,, Telangana, Telangana, 500033.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG1983PLC004356

  • Registration Number

    004356

  • Incorporation Date

    29 December 1983

  • Authorized Capital

    ₹4.20 Cr

  • Paid-Up Capital

    ₹3.70 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.20 Cr
  • Paid Up Capital ₹ 3.70 Cr
  • Company Age 42 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 70.24 Cr
  • Satisfied Charges ₹ 46.68 Cr
  • Revenue Growth **** 0.95%
  • Profit Growth **** 1040.70%
  • Ebitda **** -13.53%
  • Net Worth 1.55%
  • Total Assets **** 8.97%
Company report

Sreepathi Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sreepathi Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sreepathi Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Srinivas Isola Managing Director 09 Mar 2006 Current
Satya Isola Akhil Director 27 Aug 2009 Current
Karthik Isola Chandra Director 04 Jul 2018 Current
Shyamala Isola Whole-Time Director 08 Apr 2006 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 Oct 2009 Past
Pramod Abcsdd Director 03 Jul 2018 Past
Pramod Abcsdd Director 03 Jul 2018 Past
Pramod Abcsdd Director 05 Mar 2016 Past
Pramod Abcsdd Director 03 Jul 2018 Past
Pramod Abcsdd Additional Director 29 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sreepathi Pharmaceuticals.

Sreepathi Pharmaceuticals Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 0.95% increase. The company also saw a substantial improvement in profitability, with a 1040.7% increase in profit. The company's net worth moved up by a moderate rise of 1.55%.

Sreepathi Pharmaceuticals revenue growth over time
Sreepathi Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 0.95%
*******
*******
*******
*******
Revenue from Operations
*******
 0.53%
*******
*******
*******
*******
Total Assets
*******
 8.97%
*******
*******
*******
*******
Profit or Loss
*******
 1040.70%
*******
*******
*******
*******
Net Worth
*******
 1.55%
*******
*******
*******
*******
EBITDA
*******
 -13.53%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sreepathi Pharmaceuticals?

In 2024, Sreepathi Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹702,414,000.00

Satisfied Charges

₹466,800,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 40.49 Cr
  • Yes Bank Limited : 29.75 Cr
Latest Charge Details
Date Lender Amount Status
28 Sep 2018 Yes Bank Limited ₹29.75 Cr Open
03 Nov 2015 Hdfc Bank Limited ₹40.49 Cr Open
19 Nov 2015 The Hongkong And Shanghai Banking Corporation Limited ₹1.20 Cr Satisfied
19 Nov 2015 The Hongkong And Shanghai Banking Corporation Limited ₹17.00 Cr Satisfied
12 Apr 1997 State Bank Of Hyderabad ₹4.80 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sreepathi Pharmaceuticals?

Sreepathi Pharmaceuticals has a workforce of 119 employees as of Aug 11, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sreepathi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sreepathi Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sreepathi Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Sreepathi Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Sreepathi Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.

  • Charges

    The activity A charge with Hdfc Bank Limited of Rs. 40.49 Cr registered on 03 Nov 2015 with Charge ID 10603731 was modified on 05 Mar 2024. was completed.

  • Charges

    Progress on A charge with Yes Bank Limited of Rs. 29.75 Cr registered on 28 Sep 2018 with Charge ID 100214542 was modified on 22 Sep 2022. was documented.

  • Charges

    Progress on A charge registered on 19 Nov 2015 via Charge ID 10604186 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 04 Feb 2019. was documented.

  • Charges

    A charge registered on 19 Nov 2015 via Charge ID 10604209 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 04 Feb 2019. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sreepathi Pharmaceuticals Limited?

The CIN of Sreepathi Pharmaceuticals Limited is U24239TG1983PLC004356.

Where is Sreepathi Pharmaceuticals Limited headquartered?

Sreepathi Pharmaceuticals Limited is headquartered at Plot.No.22B, H.No.8-2-293/82/A/22/B, Road.No.2, Jubilee Hills,, Telangana, Telangana, 500033.

When was Sreepathi Pharmaceuticals Limited incorporated?

Sreepathi Pharmaceuticals Limited was incorporated on 29 December 1983.

Who are the current directors of Sreepathi Pharmaceuticals Limited?

The current directors of Sreepathi Pharmaceuticals Limited are

What is the primary industry of Sreepathi Pharmaceuticals Limited?

The primary industry of Sreepathi Pharmaceuticals Limited is Manufacturing.

Is Sreepathi Pharmaceuticals Limited a listed company?

Sreepathi Pharmaceuticals Limited is unlisted.

What is the capital structure of Sreepathi Pharmaceuticals Limited?

The authorized capital of Sreepathi Pharmaceuticals Limited is ₹4.20 Cr, and the paid-up capital is ₹3.70 Cr.

What is the compliance status of Sreepathi Pharmaceuticals Limited?

The compliance status of Sreepathi Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available